Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 15197276.
- Also identified by PMC identifier 438994.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Degeneration of the nigrostriatal dopaminergic pathway, the hallmark of Parkinson's disease, can be recapitulated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-intoxicated mice. Herein, we demonstrate that adoptive transfer of copolymer-1 immune cells to MPTP recipient mice leads to T cell accumulation within the substantia nigra pars compacta, suppression of microglial activation, and increased local expression of astrocyte-associated glial cell line-derived neurotrophic factor. This immunization strategy resulted in significant protection of nigrostriatal neurons against MPTP-induced neurodegeneration that was abrogated by depletion of donor T cells. Such vaccine treatment strategies may provide benefit for Parkinson's disease.
Medical subject headings
- Adoptive Transfer
- Coat Protein Complex I
- Dopamine
- Mesencephalon
- Neurons
- Parkinsonian Disorders